| 臺大學術典藏 |
2022-08-09T03:51:00Z |
Growth of ternary silicon carbon nitride as a new wide bandgap material
|
Chen L.C.; Chen C.K.; Bhusari D.M.; Chen K.H.; Wei S.L.; Chen Y.F.; Jong Y.C.; Lin D.Y.; Li C.F.; Huang Y.S.; Chen L.C.; Chen C.K.; Bhusari D.M.; Chen K.H.; Wei S.L.; Chen Y.F.; Jong Y.C.; Lin D.Y.; Li C.F.; Huang Y.S.; LI-CHYONG CHEN |
| 臺大學術典藏 |
2022-04-29T08:10:01Z |
Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers
|
MING-WHEI YU; Hsu F.-C.; Sheen I.-S.; Chu C.-M.; Lin D.-Y.; Chen C.-J.; Liaw Y.-F. |
| 臺大學術典藏 |
2022-03-30T03:50:46Z |
Estrogenic effects in the influents and effluents of the drinking water treatment plants
|
Gou Y.-Y.; Lin S.; Que D.E.; Tayo L.L.; Lin D.-Y.; Chen K.-C.; Chen F.-A.; Chiang P.-C.; GEN-SHUH WANG; Hsu Y.-C.; Chuang K.P.; Chuang C.-Y.; Tsou T.-C.; Chao H.-R. |
| 臺大學術典藏 |
2022-02-23T02:12:42Z |
Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: Role of viral infection
|
Tai D.-I.; CHIEN-HUNG CHEN; Chang T.-T.; Chen S.-C.; Liao L.-Y.; Kuo C.-H.; Chen Y.; Chen G.-H.; Yang S.-S.; Tang H.-S.; Lin H.H.; Lin D.-Y.; Lo S.K.; Du J.-M.; Lin K.-C.; Changchien C.-S.; Chang W.-Y.; Sheu J.-C.; Liaw Y.-F.; Chen D.-S.; Sung J.-L. |
| 臺大學術典藏 |
2022-02-23T02:12:41Z |
Hepatitis B virus transmission and hepatocarcinogenesis: A 9 year retrospective cohort of 13 676 relatives with hepatocellular carcinoma
|
CHIEN-HUNG CHEN; Chen Y.Y.; Chen G.-H.; Yang S.-S.; Tang H.-S.; Lin H.H.; Lin D.-Y.; Lo S.K.; Du J.-M.; Chang T.-T.; Chen S.-C.; Liao L.-Y.; Kuo C.-H.; Lin K.-C.; Tai D.-I.; Changchien C.-S.; Chang W.-Y.; Sheu J.-C.; Chen D.-S.; Liaw Y.-F.; Sung J.-L. |
| 臺大學術典藏 |
2022-02-22T05:34:37Z |
Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: Role of viral infection
|
Tai D.-I.; CHIEN-HUNG CHEN; Chang T.-T.; Chen S.-C.; Liao L.-Y.; Kuo C.-H.; Chen Y.; Chen G.-H.; Yang S.-S.; Tang H.-S.; Lin H.H.; Lin D.-Y.; Lo S.K.; Du J.-M.; Lin K.-C.; Changchien C.-S.; Chang W.-Y.; Sheu J.-C.; Liaw Y.-F.; Chen D.-S.; Sung J.-L. |
| 臺大學術典藏 |
2022-02-22T05:34:35Z |
Hepatitis B virus transmission and hepatocarcinogenesis: A 9 year retrospective cohort of 13 676 relatives with hepatocellular carcinoma
|
CHIEN-HUNG CHEN; Chen Y.Y.; Chen G.-H.; Yang S.-S.; Tang H.-S.; Lin H.H.; Lin D.-Y.; Lo S.K.; Du J.-M.; Chang T.-T.; Chen S.-C.; Liao L.-Y.; Kuo C.-H.; Lin K.-C.; Tai D.-I.; Changchien C.-S.; Chang W.-Y.; Sheu J.-C.; Chen D.-S.; Liaw Y.-F.; Sung J.-L. |
| 臺大學術典藏 |
2022-01-24T09:32:03Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
CHUN-JEN LIU; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
| 臺大學術典藏 |
2022-01-24T09:31:38Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
CHUN-JEN LIU; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
| 臺大學術典藏 |
2022-01-22T00:04:25Z |
Large stress-induced anisotropy in soft magnetic films for synthetic spin valves
|
Chang, H. W.; Yuan, F. T.; Lin, D. Y.; Tseng, D. H.; Chang, W. C.; Chen, Y. S.; Lin, J. G. |
| 臺大學術典藏 |
2021-09-02T00:05:16Z |
5G radio access network design with the fog paradigm: Confluence of communications and computing
|
Ku Y.-J;Lin D.-Y;Lee C.-F;Hsieh P.-J;Wei H.-Y;Chou C.-T;Pang A.-C.; Ku Y.-J; Lin D.-Y; Lee C.-F; Hsieh P.-J; Wei H.-Y; Chou C.-T; Pang A.-C.; HUNG-YU WEI |
| 臺大學術典藏 |
2021-09-01T01:53:43Z |
Sunitinib versus sorafenib in advanced hepatocellular cancer: Results of a randomized phase III trial
|
ANN-LII CHENG; Kang Y.-K.; Lin D.-Y.; Park J.-W.; Kudo M.; Qin S.; Chung H.-C.; Song X.; Xu J.; Poggi G.; Omata M.; Lowenthal S.P.; Lanzalone S.; Yang L.; Lechuga M.J.; Raymond E. |
| 臺大學術典藏 |
2021-08-31T06:29:28Z |
A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma
|
Yen C.-J.; Kim T.-Y.; Feng Y.-H.; Chao Y.; Lin D.-Y.; Ryoo B.-Y.; Huang D.C.-L.; Schnell D.; Hocke J.; Loemb? A.-B.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-07-03T03:34:53Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu C.-J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:30Z |
Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection
|
Chen L.-T.; Chen M.-F.; Li L.-A.; Lee P.-H.; Jeng L.-B.; Lin D.-Y.; Wu C.-C.; Mok K.-T.; Chen C.-L.; Lee W.-C.; Chau G.-Y.; Chen Y.-S.; Lui W.-Y.; Hsiao C.-F.; Whang-Peng J.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:06Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu C.-J.; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-02-02T00:47:03Z |
Negative modulation of androgen receptor transcriptional activity by Daxx
|
Lin D.-Y.;Fang H.-I.;Ma A.-H.;Huang Y.-S.;Yeong-Shiau Pu;Jenster G.;Kung H.-J.;Shih H.-M.; Lin D.-Y.; Fang H.-I.; Ma A.-H.; Huang Y.-S.; YEONG-SHIAU PU; Jenster G.; Kung H.-J.; Shih H.-M. |
| 臺大學術典藏 |
2020-11-19T03:19:55Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu C.-J.; PO-HUANG LEE; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
| 臺大學術典藏 |
2020-11-19T03:19:36Z |
Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection
|
Chen L.-T.;Chen M.-F.;Li L.-A.;Po-Huang Lee;Jeng L.-B.;Lin D.-Y.;Wu C.-C.;Mok K.-T.;Chen C.-L.;Lee W.-C.;Chau G.-Y.;Chen Y.-S.;Lui W.-Y.;Hsiao C.-F.;Whang-Peng J.;Chen P.-J.; Chen L.-T.; Chen M.-F.; Li L.-A.; PO-HUANG LEE; Jeng L.-B.; Lin D.-Y.; Wu C.-C.; Mok K.-T.; Chen C.-L.; Lee W.-C.; Chau G.-Y.; Chen Y.-S.; Lui W.-Y.; Hsiao C.-F.; Whang-Peng J.; Chen P.-J. |
| 臺大學術典藏 |
2020-11-19T03:19:23Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J.; Liu C.-J.; Chang J.; PO-HUANG LEE; Lin D.-Y.; Wu C.-C.; Jeng L.-B. |
| 臺大學術典藏 |
2020-09-30T03:22:29Z |
Multicenter study of skin rashes and hepatotoxicity in antiretroviral-na?ve HIVpositive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan
|
Lee Y.-C.; Liu C.-E.; Wu P.-Y.;Cheng C.-Y.;Liu C.-E.;Lee Y.-C.;Yang C.-J.;Tsai M.-.S.;Cheng S.-H.;Lin S.-P.;Lin D.-Y.;Wang N.-C.;Lee Y.-.C.;Sun H.-Y.;Tang H.-J.;Chien-Ching Hung; Wu P.-Y.; Cheng C.-Y.; Yang C.-J.; Tsai M.-.S.; Cheng S.-H.; Lin S.-P.; Lin D.-Y.; Wang N.-C.; Lee Y.-.C.; Sun H.-Y.; Tang H.-J.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2020-06-11T06:25:03Z |
5G radio access network design with the fog paradigm: Confluence of communications and computing
|
Ku, Y.-J.;Lin, D.-Y.;Lee, C.-F.;Hsieh, P.-J.;Wei, H.-Y.;Chou, C.-T.;Pang, A.-C.; Ku, Y.-J.; Lin, D.-Y.; Lee, C.-F.; Hsieh, P.-J.; Wei, H.-Y.; Chou, C.-T.; Pang, A.-C.; CHUN-TING CHOU |
| 臺大學術典藏 |
2020-06-11T06:24:47Z |
5G radio access network design with the fog paradigm: Confluence of communications and computing
|
Ku, Y.-J.;Lin, D.-Y.;Lee, C.-F.;Hsieh, P.-J.;Wei, H.-Y.;Chou, C.-T.;Pang, A.-C.; Ku, Y.-J.; Lin, D.-Y.; Lee, C.-F.; Hsieh, P.-J.; Wei, H.-Y.; Chou, C.-T.; Pang, A.-C.; CHUN-TING CHOU |
| 臺大學術典藏 |
2020-02-25T06:12:01Z |
Estrogenic effects in the influents and effluents of the drinking water treatment plants
|
PEN-CHI CHIANG;Chao, H.-R.;Tsou, T.-C.;Chuang, C.-Y.;Chuang, K.P.;Hsu, Y.-C.;Wang, G.-S.;Chiang, P.-C.;Chen, F.-A.;Chen, K.-C.;Lin, D.-Y.;Tayo, L.L.;Que, D.E.;Lin, S.;Gou, Y.-Y.; Gou, Y.-Y.; Lin, S.; Que, D.E.; Tayo, L.L.; Lin, D.-Y.; Chen, K.-C.; Chen, F.-A.; Chiang, P.-C.; Wang, G.-S.; Hsu, Y.-C.; Chuang, K.P.; Chuang, C.-Y.; Tsou, T.-C.; Chao, H.-R.; PEN-CHI CHIANG |
| 臺大學術典藏 |
2020-02-19T09:33:57Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu C.-J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; MING-CHIH HO; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
